5 Best Penny Stocks to Buy According to Billionaire Ken Griffin

4. Allogene Therapeutics Inc (NASDAQ:ALLO)

Number of Hedge Fund Holders: 20
Upside Potential: 79%

Allogene Therapeutics Inc (NASDAQ:ALLO) is a clinical-stage immune-oncology company developing and commercializing genetically engineered cancer treatment therapies. Allogene Therapeutics Inc (NASDAQ:ALLO) develops, manufactures, and commercializes UCART19, a T-cell product candidate for treating pediatric and adult patients with R/R CD19-positive B-cell ALL.

As of the fourth quarter of last year, 20 out of the 933 hedge funds in Insider Monkey’s database had held a stake in Allogene Therapeutics Inc (NASDAQ:ALLO). Ken Griffin’s Citadel Investment Group owned the most significant stake in Chord Energy in Q3, worth $13 million.

Follow Allogene Therapeutics Inc. (NASDAQ:ALLO)

[/company-follow-email]